Human primary hepatocytes
Ended Purchase Order Awarded
- Contract number
- HHSF223201710414A
- Awardee
-
In Vitro Admet Laboratories, LLC UEI C3RMLJZXLEE5
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $36,699
Award facts
- Opportunity
-
- FDA172231177415 Solicitation number
- Human Primary Hepatocytes Award Notice · Posted Jan 26, 2017
- Contract value 100% obligated
- $36,698.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Jefferson, AR 72079, USA
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSF223201710414A?
HHSF223201710414A was awarded to In Vitro Admet Laboratories, LLC by Food and Drug Administration (Department of Health and Human Services) on August 23, 2017.
How much is contract HHSF223201710414A worth?
The government has obligated $36,699 on HHSF223201710414A.
Was contract HHSF223201710414A competed?
The extent of competition for HHSF223201710414A was competed under sap. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award